Poly(ADP-ribose) polymerase inhibitors

Current Medicinal Chemistry

Volumn 10, Issue 4, 2003, Pages 321-340

  Southan, Garry J ^a   Szabó, Csaba ^a  

^a INOTEK CORPORATION   (United States)

Author keywords

Aminobenzamide; Apoptosis; Arthritis; Colitis; Diabetes; DNA repair; Inflammation; Myocardial ischemia; Necrosis; Nicotinamide; Nitric oxide; Peroxynitrite; Poly(ADB ribose) polymerase; Reperfusion; Stroke; Uveitis

Indexed keywords

3 AMINOBENZAMIDE; 3 METHOXYBENZAMIDE; BENZAMIDE DERIVATIVE; BENZIMIDAZOLE DERIVATIVE; BENZYL DERIVATIVE; CELL NUCLEUS RECEPTOR; DNA TOPOISOMERASE INHIBITOR; HISTONE; INDOLE DERIVATIVE; ISOCARBOSTYRIL DERIVATIVE; N (5,6 DIHYDRO 6 OXO 2 PHENANTHRIDINYL) 2 DIMETHYLAMINOACETAMIDE; NAPHTHYRIDINE DERIVATIVE; NICOTINAMIDE; NICOTINAMIDE ADENINE DINUCLEOTIDE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE INHIBITOR; O (2 HYDROXY 3 PIPERIDINOPROPYL) 3 CARBOXYLIC ACID AMIDOXIME; PHENANTHRIDINE DERIVATIVE; PHTHALAZINE DERIVATIVE; PIPERAZINE DERIVATIVE; PYRAZINAMIDE; QUINAZOLINE DERIVATIVE; QUINAZOLINONE DERIVATIVE; RADIOSENSITIZING AGENT; SULFONAMIDE; SULFONIC ACID DERIVATIVE; TOPOTECAN; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ALLERGIC ENCEPHALOMYELITIS; ANTINEOPLASTIC ACTIVITY; ANTIVIRAL ACTIVITY; ARTHRITIS; BRAIN INJURY; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; COLITIS; DIABETES MELLITUS; DNA DAMAGE; DNA STRAND BREAKAGE; DRUG SAFETY; DRUG STRUCTURE; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME MECHANISM; HEART MUSCLE ISCHEMIA; HUMAN; INFLAMMATION; NONHUMAN; OXIDATIVE STRESS; PROTEIN DNA BINDING; REVIEW; SHOCK; SIGNAL TRANSDUCTION; STROKE; STRUCTURE ANALYSIS;

EID: 0037239590     PISSN: 09298673     EISSN: None     Source Type: Journal    
DOI: 10.2174/0929867033368376     Document Type: Review

References (218)

1. Ueda, K.; Hayaishi, O. Annu. Rev. Biochem., 1985, 54, 73.
2. Szabo, C.; Dawson, V.L. Trends Pharmacol. Sci., 1998,19, 287.
3. De Murcia, G.; Schreiber, V.; Molinete, M.; Saulier, B.; Poch, O.; Masson, M.; Niedergang, C.; Menissier-de Murcia, J. Mol. Cell Biochem., 1994, 138, 15.
4. Chiarugi, A.; Trends Pharmacol. Sci., 2002, 23, 122.
5. De Murcia, G.; Shall, S. (Eds.) From DNA damage and stress signaling to cell death; poly ADP-ribosylation reactions. Oxford University Press, Oxford, England, 2000.
6. Szabo, C. (ed) Cell death: the role of PARP. CRC Press, Boca Raton, FL. 2000.
7. Zhang, J. (ed) PARP as a therapeutic target. CRC Press, Boca Raton, FL. 2002.
8. Decker, P.; Muller, S.; Curr. Pharm. Biotechnol., 2002, 3, 275.
9. Virag, L.; Szabo C. Pharmacol. Rev., 2002, 54, 375.
10. Heller, B.; Wang, Z.Q.; Wagner, E.F.; Radons, J.; Burkle, A.; Fehsel, K.; Burkart, V.; Kolb, H. J. Biol. Chem., 1995, 270, 11176.
11. Szabo, C.; Zingarelli, B.; O'Connor, M.; Salzman, A.L. Proc. Natl. Acad. Sci. USA, 1996, 93, 1753.
12. Virag, L.; Salzman, A.L.; Szabo, C. J. Immunol., 1998, 161, 3753.
13. Ha, H.C.; Snyder, S.H. Proc. Natl. Acad. Sci. USA, 1999, 96, 13978.
14. Cole, K.K.; Perez-Polo, J.R. J. Neurochem., 2002, 82, 19-29.
15. Szabo, C.; Virag, L.; Cuzzocrea, S.; Scott, G.S.; Hake, P.; O'Connor, M.P.; Zingarelli, B.; Salzman, A.; Kun, E. Proc. Natl. Acad. Sci. USA, 1998, 95, 3867-72.
16. Zingarelli, B.; Salzman, A.L.; Szabo, C. Circ. Res., 1998, 83, 85-94.
17. Oliver, F.J.; Menissier-de Murcia, J.; Nacci, C.; Decker, P.; Andriantsitohaina, R.; Muller, S.; de la Rubia, G.; Stoclet, J.C.; de Murcia, G. EMBO J., 1999, 18, 4446.
18. Ullrich, O.; Diestel, A.; Eyupoglu, I.Y.; Nitsch, R. Nat. Cell Biol., 2001, 3, 1035.
19. Simbulan-Rosenthal, C.M.; Ly, D.H.; Rosenthal, D.S.; Konopka, G.; Luo, R.; Wang, Z.Q.; Schultz, P.G.; Smulson, M.E. Proc. Natl. Acad. Sci. USA, 2000, 97, 11274.
20. Ha, H.C.; Hester, L.D.; Snyder, S.H. Proc. Natl. Acad. Sci. USA, 2002, 99, 3270.
21. Eliasson, M.J.; Sampei, K.; Mandir, A.S.; Hurn, P.D.; Traystman, R.J.; Bao, J.; Pieper, A.; Wang, Z.Q.; Dawson, T.M.; Snyder, S.H.; Dawson, V.L. Nat. Med., 1997, 3, 1089.
22. Endres, M.; Wang, Z.Q.; Namura, S.; Waeber, C.; Moskowitz, M.A. J. Cereb. Blood Flow Metab., 1997, 17, 1143.
23. Whalen, M.J.; Clark, R.S.; Dixon, C.E.; Robichaud, P.; Marion, D.W.; Vagni, V.; Graham, S.H.; Virag, L.; Hasko, G.; Stachlewitz, R.; Szabo, C.; Kochanek, P.M. J. Cereb. Blood Flow Metab., 1999, 19, 835.
24. Mandir, A.S.; Przedborski, S.; Jackson-Lewis, V.; Wang, Z.Q.; Simbulan-Rosenthal, C.M.; Smulson, M.E.; Hoffman, B.E.; Guastella, D.B.; Dawson, V.L.; Dawson, T.M. Proc. Natl. Acad. Sci. USA, 1999, 96, 5774.
25. Grupp, I.L.; Jackson, T.M.; Hake, P.; Grupp, G.; Szabo, C. J. Mol. Cell Cardiol., 1999, 31, 297-303.
26. Yang, Z.; Zingarelli, B.; Szabo, C. Shock, 2000, 13, 60-6.
27. Pieper, A.A.; Walles, T.; Wei, G.; Clements, E.E.; Verma, A.; Snyder, S.H.; Zweier, J.L. Mol. Med., 2000, 6, 271.
28. Burkart, V.; Wang, Z.Q.; Radons, J.; Heller, B.; Herceg, Z.; Stingl, L.; Wagner, E.F.; Kolb, H. Nat. Med., 1999, 5, 314.
29. Pieper, A.A.; Brat, D.J.; Krug, D.K.; Watkins, C.C.; Gupta, A.; Blackshaw, S.; Verma, A.; Wang, Z.Q.; Snyder, S.H. Proc. Natl. Acad. Sci. USA, 1999, 96, 3059.
30. Masutani, M.; Suzuki, FL; Kamada, N.; Watanabe, M.; Ueda, O.; Nozaki, T.; Jishage, K.; Watanabe, T.; Sugimoto, T.; Nakagama, H.; Ochiya, T.; Sugimura, T. Proc. Natl. Acad. Sci. USA, 1999, 96, 2301.
31. Mabley, J.G.; Suarez-Pinzon, W.L.; Hasko, G.; Salzman, A.L.; Rabinovitch, A.; Kun, E.; Szabo, C. Br. J. Pharmacol., 2001, 133. 909.
32. Soriano, F.G.; Virag, L.; Szabo, C. J. Mol. Med., 2001, 79, 437.
33. Zingarelli, B.; Szabo, C.; Salzman, A. L. Gastroenterology, 1999, 116, 335.
34. Liaudet, L.; Soriano, F.G.; Szabo, E.; Virag, L.; Mabley, J.G.; Salzman, A.L.; Szabo, C. Proc. Natl. Acad. Sci. USA, 2000, 97, 10203.
35. Soriano, F.G.; Liaudet, L.; Szabo, E.; Virag, L.; Mabley, J.G.; Pacher, P.; Szabo, C. Shock, 2002, 17, 286.
36. Liaudet, L.; Pacher, P.; Mabley, J.G.; Virag, L.; Soriano, F.G.; Hasko, G.; Szabo, C. Am. J. Respir. Crit. Care Med., 2002, 165, 372.
37. Clark, J.B.; Ferris, J.M. Pinder, S. Biochem. Biophys. Acta, 1971, 238, 82.
38. Shall, S. J. Biochem., 1975, 77, 2.
39. Purnell, M.R.; Whish, W.J.D. Biochem. J., 1980, 185, 775.
40. Sims, J.; Sikorski, G.W.; Catino, D.M.; Berger, S.J.; Berger, N.A. Biochemistry, 1985, 21, 1813.
41. Cantoni, O.; Sestili, P.; Spadoni, G.; Balsamini, C.; Cucchiarini, L.; Cattabeni, F. Biochem. Int., 1987, 15, 329.
42. McLick, J.; Hakam, A.; Bauer, P.I.; Kun, E.; Zacharias, D.E.; Glusker, J.P. Biochim. Biophys. Acta, 1987, 6, 909.
43. Tokime, T.; Nozaki, K.; Sugino, T.; Kikuchi, H.; Hashimoto, N.; Ueda, K. J. Cereb. Blood Flow Metab., 1998, 18, 991.
44. Ducrocq, S.; Benjelloun, N.; Plotkine, M.; Ben-Ari, Y.; Charriaut-Marlangue, C. J. Neurochem., 2000, 74, 2504.
45. Ding, Y.; Zhou, Y.; Lai, Q.; Li, J.; Gordon, V.; Diaz, F.G. Brain Res., 2001, 915, 210.
46. Zingarelli, B.; Cuzzocrea, S.; Zsengeller, Z.; Salzman, A.L.; Szabo, C. Cardiovasc. Res., 1997, 36, 205.
47. Thiemermann, C.; Bowes, J.; Myint, F.P.; Vane, J.R. Proc. Natl. Acad. Sci. USA, 1997, 94, 679.
48. Bowes, J.; Ruetten, H.; Martorana, P.A.; Stockhausen, H.; Thiemermann, C. Eur. J. Pharmacol., 1998, 359, 143.
49. Liaudet, L.; Yang, Z.; Al-Affar, E.B.; Szabo, C. Mol. Med., 2001, 7, 406.
50. Liaudet, L.; Szabo, E.; Timashpolsky, L.; Virag, L.; Cziraki, A.; Szabo, C. Br. J. Pharmacol., 2001, 133, 1424.
51. Cuzzocrea, S.; Zingarelli, B.; Costantino, G.; Szabo, A.; Salzman, A.L.; Caputi, A.P.; Szabo, C. Br. J. Pharmacol., 1997, 121, 1065.
52. Liaudet, L.; Szabo, A.; Soriano, F.G.; Zingarelli, B.; Szabo, C.; Salzman, A.L. Shock, 2000, 14, 134.
53. Martin, D.R.; Lewington, A.J.; Hammerman, M.R.; Padanilam, B.J. Am. J. Physiol., 2000, 279, R1834.
54. Chatterjee, P.K.; Zacharowski, K.; Cuzzocrea, S.; Otto, M.; Thiemermann, C. FASEB J., 2000, 14, 641.
55. Bowes, J.; Thiemermann, C. Br. J. Pharmacol., 1998, 124, 1254.
56. Tabuchi, K.; Ito, Z.; Tsuji, S.; Nakagawa, A.; Serizawa, F.; Hara, A.; Kusakari, J. Ann. Otol. Rhinol. Laryngol., 2001, 110, 118.
57. Chiang, S.K.; Lam, T.T. Invest. Ophthalmol. Vis. Sci., 2000, 41, 3210.
58. Szabo, C.; Zingarelli, B.; Salzman, A.L. Circ. Res., 1996, 78, 1051.
59. Szabo, C.; Cuzzocrea, S.; Zingarelli, B.; O'Connor, M.; Salzman, A.L. J. Clin. Invest., 1997, 100, 723.
60. Szabo, A.; Salzman, A.L.; Szabo, C. Life Sci., 1998, 63, 2133.
61. McDonald, M.C.; Filipe, H.M.; Thiemermann, C. Br. J. Pharmacol., 1999, 128, 1339.
62. Albertini, M.; Clement, M.G.; Lafortuna, C.L.; Caniatti, M.; Magder, S.; Abdulmalek, K.; Hussain, S.N. J. Crit. Care., 2000, 15, 73.
63. Watts, J.A.; Grattan, R.M.; II, Whitlow, B.S.; Kline, J.A. Am. J. Physiol., 2001, 281, G498.
64. Szabo, C.; Lim, L.H.; Cuzzocrea, S.; Getting, S.J.; Zingarelli, B.; Flower, R.J.; Salzman, A.L.; Perretti, M. J. Exp. Med., 1997, 186, 104.
65. Cuzzocrea, S.; Zingarelli, B.; Gilad, E.; Hake, P.; Salzman, A.L.; Szabo, C. Eur. J. Pharmacol., 1998,342, 67.
66. Cuzzocrea, S.; Costantino, G.; Zingarelli, B.; Caputi, A.P. Life Sci., 1999, 65, 957.
67. Jijon, H.B.; Churchill, T.; Malfair, D.; Wessler, A.; Jewell, L.D.; Parsons, H.G.; Madsen, K.L. Am. J. Physiol., 2000, 279, G641.
68. Koedel, U.; Winkler, F.; Angele, B.; Fontana, A.; Pfister, H.W. J. Cereb. Blood Flow Metab., 2002, 22, 39.
69. Ayoub, I.A.; Lee, E.J.; Ogilvy, C.S.; Beal, M.F.; Maynard, K.I. Neurosci. Lett., 1999, 259, 21.
70. Sakakibara, Y.; Mitha, A.P.; Ogilvy, C.S.; Maynard, K.I. Neurosci. Lett., 2000, 281, 111.
71. Mokudai, T.; Ayoub, I.A.; Sakakibara, Y.; Lee, E.J.; Ogilvy, C.S.; Maynard, K.I. Stroke, 2000, 31, 1679.
72. Ayoub, I.A.; Maynard, K.I. Neuroreport., 2002, 13, 213.
73. Yang, J.; Klaidman, L.; Chang, M.; Kem, S.; Sugawara, T.; Chan, P.; Adams J. J. Pharmacol. Biochem. Behav., 2002, 73, 901.
74. Chen, C.F.; Wang, D.; Hwang, C.P.; Liu, H.W.; Wei, J.; Lee, R.P.; Chen, H.I. J. Biomed. Sci., 2001, 8, 446.
75. Halmosi, R.; Berente, Z.; Osz, E.; Toth, K.; Literati-Nagy, P.; Sumegi, B. Mol. Pharmacol., 2001, 59, 1497.
76. Zingarelli, B.; Salzman, A.L.; Szabo, C. Shock, 1996, 5, 258.
77. Kroger, H.; Dietrich, A.; Gratz, R.; Klewer, M.; Wohlert, H.; Ehrlich, W. Adv. Exp. Med. Biol., 1996, 398, 523.
78. Kroger, H.; Hauschild, A.; Ohde, M.; Bache, K.; Voigt, W.P.; Ehrlich, W. Inflammation, 1999, 23, 111.
79. Jonas, W.B.; Rapoza, C.P.; Blair, W.F. Inflamm. Res., 1996, 45, 330.
80. Uchigata, Y.; Yamamoto, H.; Kawamura, A.; Okamoto, H. J. Biol. Chem., 1982, 257, 6084.
81. Radons, J.; Heller, B.; Burkle, A.; Hartmann, B.; Rodriguez, M.L.; Kroncke, K.D.; Burkart, V.; Kolb, H. Biochem. Biophys. Res. Commun., 1994, 199, 1270.
82. Uchigata, Y.; Yamamoto, H.; Nagai, H.; Okamoto, H. Diabetes, 1983, 32, 316.
83. Yonemura, Y.; Takashima, T.; Miwa, K.; Miyazaki, I.; Yamamoto, H.; Okamoto, H. Diabetes, 1984, 33, 401.
84. Masiello, P.; Cubeddu, T.L.; Frosina, G.; Bergamini, E. Diabetologia, 1985, 28, 683.
85. Shima, K.; Hirota, M.; Sato, M.; Numoto, S.; Oshima, I. Diabetes Res. Clin. Pract., 1987, 3, 135.
86. Mendola, J.; Wright, J.R.; Jr.; Lacy, P.E. Diabetes, 1989, 38, 379.
87. Masiello, P.; Novelli, M.; Fierabracci, V.; Bergamini, E. Res. Commun. Chem. Pathol. Pharmacol., 1990, 69, 17.
88. Schatz, D.A.; Bingley, P.J. J. Pediatr. Endocrinol. Metab., 2001, 14, Suppl. 1, 619-22.
89. Buyukgebiz, A.; Cemeroglu, A.P.; Bober, E.; Mohn, A.; Chiarelli, F. J. Pediatr. Endocrinol. Metab., 2001, 14, 1585.
90. Mabley, J.; Virág, L.; Szabo, C. Role of poly (ADP-ribose) polymerase activation in the pathogenesis of diabetes mellitus and diabetic vascular dysfunction. In: Zhang J, C (ed) PARP as a therapeutic target. CRC Press, Boca Raton, FL. 2002. pp. 277-319.
91. Knip, M.; Douek, I.F.; Moore, W.P.; Gillmor, H.A.; McLean, A.E.; Bingley, P.J.; Gale, E.A. Diabetologia., 2000, 43, 1337.
92. Rankin, P.W.; Jacobson, E.L.; Benjamin, R.C.; Moss, J.; Jacobson, M.K. J. Biol. Chem., 1989, 264, 4312.
93. Banasik, M.; Komura, H.; Shimoyama, M.; Ueda, K. J. Biol. Chem. 1992, 267, 1569.
94. Pero, R.W.; Olsson, A.; Lindgren, H.; Leanderson, T. Clinical development of the nicotinamides and benzamides involving PARP as a molecular target. In: Zhang J, C (ed) PARP as a therapeutic target. CRC Press, Boca Raton, FL. 2002. pp. 205-221.
95. Pero, R.W.; Olsson, A.; Amiri, A.; Chaplin, D. Cancer Detect. Prev., 1998, 22, 225.
96. Szabados, E.; Literati-Nagy, P.; Farkas, B.; Sumegi, B. Biochem. Pharmacol., 2000, 59, 937.
97. Halmosi, R.; Berente, Z.; Osz, E.; Toth, K.; Literati-Nagy, P.; Sumegi, B. Mol. Pharmacol., 2001, 59, 1497.
98. Farkas, B.; Magyarlaki, M.; Csete, B.; Nemeth, J.; Rabloczky, G.; Bernath, S.; Literati Nagy, P.; Sumegi, B. Biochem. Pharmacol., 2002, 63, 921.
99. Racz, I.; Tory, K.; Gallyas, F. Jr.; Berente, Z.; Osz, E.; Jaszlits, L.; Bernath, S.; Sumegi, B.; Rabloczky, G.; Literati-Nagy, P. Biochem. Pharmacol., 2002, 63, 1099.
100. Suto, M.J.; Turner, W.R.; Arundel-Suto, C.M.; Werbel, L.M.; Sebolt-Leopold, J.S. Anticancer Drug Res., 1991, 7, 107.
101. Warner Lambert. US 5177075, 1993.
102. Warner Lambert. EP 0 355 750, 1990.
103. Warner Lambert. US 5391554, 1995.
104. Curtin, N.J.; Golding, B.T.; Griffin, R.J.; Newell, D.R.; Roberts, M.J.; Srinivasen, S.; White, A. In: From DNA damage and Stress Signaling to Cell Death; de Murcia; Shall S., Eds.; Oxford University Press: New York, 2000; pp 177-206.
105. Arundel-Suto, C.M.; Scavone, S.V.; Turner, W.R.; Suto, M.J.; Sebolt-Leopold, J.S. Radiat. Res., 1991, 126, 367.
106. Sebolt-Leopold, J.S.; Scavone, S.V. Int. J. Radiat. Oncol. Biol. Phys., 1992, 22, 619.
107. Boulton, S.; Pemberton, L.C.; Porteous, J.K.; Curtin, N.J.; Griffin, R.J., Golding, B.T.; Durkacz, B.W. Br. J. Cancer, 1995, 72, 849.
108. Burkart, V.; Blaeser, K.; Kolb, H. Potent beta-cell protection in vitro by an isoquinolinone-derived PARP inhibitor. Horm. Metab. Res., 1999, 31, 641.
109. Docherty, J.C.; Kuzio, B.; Silvester, J.A.; Bowes, J.; Thiemermann, C. Br. J. Pharmacol., 1999, 127, 1518.
110. Cuzzocrea, S.; McDonald, M.C.; Mazzon, E.; Dugo, L.; Serraino, I.; Threadgill, M.; Caputi, A.P.; Thiemermann, C. Biochem. Pharmacol., 2002, 63, 293.
111. Wayman, N.; McDonald, M.C.; Thompson, A.S.; Threadgill, M.D; Thiemermann, C. Eur. J. Pharmacol., 2001, 430, 93.
112. Takahashi, K.; Greenberg, J.H.; Jackson, P.; Maclin, K.; Zhang, J. J. Cereb. Blood Flow Metab., 1997, 17, 137.
113. Takahashi, K.; Pieper, A.A.; Croul, S.E.; Zhang, J.; Snyder, S.H.; Greenberg, J.H. Brain Res., 1999, 829, 46.
114. Moroni, F.; Meli, E.; Peruginelli, F.; Chiarugi, A.; Cozzi, A.; Picca, R.; Romagnoli, P.; Pellicciari, R.; Pellegrini-Giampietro, D.E. Cell Death Differ., 2001, 8, 921.
115. Giovannelli, L.; Cozzi, A.; Guarnieri, I.; Dolara, P.; Moroni, F. J. Cereb. Blood Flow Metab., 2002, 22, 697.
116. Miyake, Y.; Kuge, Y.; Shimadzu, H.; Hashimoto, N.; Ishida, Y.; Shibakawa, M.; Nishimura, T. Nucl. Med. Biol., 2000, 27, 701.
117. Guilford Pharmaceuticals Inc. WO 99/59975, 1999.
118. Tang, Z.L.; Wasserloos, K.; St. Croix, C.M.; Pitt, B.R. Am. J. Physiol., 2001, 281, L243.
119. Bernges, F.; Zeller, W.J. J. Cancer Res. Clin. Oncol., 1996, 122, 665.
120. Schlicker, A.; Peschke, P.; Burkle, A.; Hahn, E.W.; Kim, J.H. Int. J. Radiat. Biol., 1999, 75, 91.
121. Smithkline Beecham WO 20/36599, 2002.
122. Guilford Pharmaceuticals Inc. US 6,346,536, 2002.
123. Zhang, J.; Lautar, S.; Huang, S.; Ramsey, C.; Cheung, A.; Li, J.H. Biochem. Biophys. Res. Commun., 2000, 278, 590.
124. Sharp, C.; Warren, A.; Oshima, T.; Williams, L.; Li, J.H.; Alexander, J.S. Inflammation, 2001, 25, 157.
125. Oshima, T.; Pavlick, K.P.; Laroux, F.S.; Verma, S.K.; Jordan, P.; Grisham, M.B.; Williams, L.; Alexander, J.S. Am. J. Physiol., 2001, 281, C1096.
126. LaPlaca, M.C.; Zhang, J.; Raghupathi, R.; Li, J.H.; Smith, F.; Bareyre, F.M.; Snyder, S.H.; Graham, D.I.; McIntosh, T.K. J. Neurotrauma, 2001, 18, 369.
127. Mazzon, E.; Serraino, I.; Li, J.H.; Dugo, L.; Caputi, A.P.; Zhang, J.; Cuzzocrea, S. Eur. J. Pharmacol., 2001, 415, 85.
128. Mazzon, E.; Dugo, L.; De, S.A.; Li, J.H.; Caputi, A.P.; Zhang, J.; Cuzzocrea, S. Shock, 2002, 17, 222.
129. Mazzon, E.; Dugo, L.; Li, J.H.;, Di Paola, R.; Genovese, T.; Caputi, A.P.; Zhang, J.; Cuzzocrea, S. Biochem. Pharmacol., 2002, 64, 327.
130. Zhang, J: Beneficial effect of GPI6150 treatmeny in multiple animal models of disease. In: Zhang J, C (ed) PARP as a therapeutic target. CRC Press, Boca Raton, FL. 2002. pp. 239-256.
131. Newcastle University Ventures Ltd. EP 0 879 820, 1995.
132. Newcastle University Ventures Ltd. US 6,310,082, 2001.
133. Newcastle University Ventures Ltd. US 6,100,283, 2000.
134. White, A.; Almassey, R.; Calvert, A.H.; Curtin, N.J.; Griffin, R.J.; Hostomsky, Z.; Maegley, K.; Newell, D.R.,; Srinivasan, S.; Golding, B.T. J. Med. Chem., 2000, 43, 4084.
135. BASF AG. WO 00/64878, 2000.
136. BASF AG. WO 00/68206, 2000.
137. BASF AG. WO 00/29384, 2000.
138. Yamanouchi Pharmaceuticals. WO 01/21615.
139. Yamanouchi Pharmaceuticals. WO 02/068407.
140. BASF AG WO 01/85687.
141. BASF AG WO 01/57038.
142. Augouron Pharmaceuticals Inc. WO 00/42040, 2000.
143. Augouron Pharmaceuticals Inc. WO 01/16136, 2001.
144. BASF AG WO 01/23386, 2001.
145. Guilford Pharmaceuticals Inc. WO 02/44183, 2002.
146. Ferraris, D.; Pargas, R.; Lautar, S.; Liang, S.; Lin, Q.; Lu, M.; Morgan, L.; Thomas, B.; Tran, S.; Williams, L.; Xu, W.; Wu, Q. Y.; Zhang J.; Zou, Y.; Kalish, V. 224th National meeting of the American Chemical Society, 2002, Boston, MA. MEDI 269.
147. Sanofi-Synthelab WO 02/42306, 2002.
148. Iconix Pharmaceuticals WO 02/44157.
149. Kudos Pharmaceuticals WO 02/36576, 2002.
150. Ono Pharmaceuticals WO 00/44726, 2002.
151. BASF AG WO 00/67734, 2000.
152. Sumitomo Pharmaceuticals WO 01/79184, 2001.
153. Guilford Pharmaceuticals Inc WO 01/16137, 2001.
154. Xu, W.; Liu, Q.; Ko, Y.; Lautar, S.; Li, J.; Lu, M.; Tran, S.; Williams, L.; Wu, Q. Y.; Zhang J.; Kalish, V. 224th National meeting of the American Chemical Society, 2002, Boston, MA. MEDI 264.
155. Guilford Pharmaceuticals Inc US 6,291,425, 2001.
156. Newcastle University Ventures Ltd. US 6015827, 2000.
157. Newcastle University Ventures Ltd. US 5756510, 1998.
158. Griffin, R.J.; Srinivasan, S.; Bowman, K.; Calvert, A.H.; Curtin, N.J.; Newell, D.R.; Pemberton, L.C.; Golding, B.T. J. Med. Chem., 1998, 41, 5247.
159. Newcastle University Ventures Ltd. EP 0 897 915, 1999.
160. Newcastle University Ventures Ltd. US 6156739, 2000.
161. Newcastle University Ventures Ltd. WO 98/33802, 1998.
162. Fujisawa Pharmaceuticals. WO 02/48117, 2002.
163. Shikwin, A.E.; Whish, W.J.D.; Threadgill, M.D. Biorg. Med. Chem., 1999, 7, 297.
164. Meiji Seika Kaisha. WO 00/42025, 2000.
165. Steinhagen, H.; Gerish, M.; Mittendorf, J.; Schlemmer, K.H.; Albrecht, B. Biorg. Med. Chem. Lett., 2002, 12, 3187.
166. Bayer, A.G. WO 02/06247, 2002.
167. Sumitomo Pharmaceuticals WO 01/79206, 2001.
168. Novartis AG WO 02/06284, 2002.
169. Inotek Corp WO 01/77075, 2001.
170. Rolli, V.; Ruf, A.; Augustin, A.; Schulz, G.; Menissier-de Murcia, J.; de Murcia, G. In From DNA damage and Stress Signaling to Cell Death; de Murcia; Shall., Eds.; Oxford University Press: New York, 2000; pp 35-79.
171. Virag, L.; Szabo, C. FASEB J., 2001, 15, 99.
172. Guilford Pharmaceuticals Inc. US 6306889, 2001.
173. Ator et al. US (Pub. No.) 2002/0028815, 2002.
174. Li, J.; Serdyuk, L.; Ferraris, D.V.; Xiao, G.; Tays, K.L.; Kletzly, P.W.; Li, W.; Lautar, S.; Zhang, J.; Kalish, V.J. Bioorganic Med. Chem. Lett., 2001, 11, 1687.
175. Guilford Pharmaceuticals Inc US (Pub. No.) 2002/0006927, 2002.
176. Guilford Pharmaceuticals Inc US WO 01/90077, 2001.
177. Inotek Corp. US 6277990, 2001.
178. Jagtap, P.; Soriano, F.G.; Virag, L.; Liaudet, L.; Mabley, J.; Szabo, E.; Hasko, G.; Marton, A.; Lorigados, C.B.; Gallyas, F.; Jr.; Sumegi, B.; Hoyt, D.G.; Baloglu, E.; VanDuzer, J.; Salzman, A.L.; Southan, G.J.;, Szabo, C. Crit. Care Med., 2002, 30, 1071.
179. Abdelkarim, G.E.; Gertz, K.; Harms, C.; Katchanov, J.; Dirnagl, U.; Szabo, C.; Endres, M. Int. J. Mol. Med., 2001, 7, 255.
180. Faro, R.; Toyoda, Y.; McCully, J.D.; Jagtap, P.; Szabo, E.; Virag, L.; Bianchi, C.; Levitsky, S.; Szabo, C.; Sellke, F.W. Ann. Thorac. Surg., 2002, 73, 575.
181. Szabo, G.; Bahrle, S.; Stumpf, N.; Sonnenberg, K.; Szabo, E.E.; Pacher, P.; Csont, T.; Schulz, R.; Dengler, T.J.; Liaudet, L.; Jagtap, P.G.; Southan, G.J.; Vahl, C.F.; Hagl, S.; Szabo, C. Circ. Res., 2002, 90, 100.
182. Goldfarb, R.D.; Marton, A.; Szabo, E.; Virag, L.; Salzman, A.L.; Glock, D.; Akhter, I.; McCarthy, R.; Parrillo, J.E.; Szabo, C. Crit. Care Med., 2002, 30, 974.
183. Garcia Soriano, F.; Virag, L.; Jagtap, P.; Szabo, E.; Mabley, J.G.; Liaudet, L.; Marton, A.; Hoyt, D.G.; Murthy, K.G.; Salzman, A.L.; Southan, G.J.; Szabo, C. Nat. Med., 2001, 7, 108.
184. Soriano, F.G.; Pacher, P.; Mabley, J.; Liaudet, L.; Szabo, C. Circ. Res., 2001, 89, 684.
185. Mabley, J.G.; Jagtap, P.; Perretti, M.; Getting, S.J.; Salzman, A.L.; Virag, L.; Szabo, E.; Soriano, F.G.; Liaudet, L.; Abdelkarim, G.E.; Hasko, G.; Marton, A.; Southan, G.; Szabo, C. Inflamm. Res., 2001,50, 561.
186. Pacher, P.; Liaudet, L.; Bai, P.; Virag, L.; Mabley, J.G,; Hasko, G.; Szabo, C. J. Pharmacol. Exp. Ther., 2002, 300, 862.
187. Pacher, P.; Liaudet, L.; Mabley, J.; Komjati, K.; Szabo, C. J. Am. Coll. Cardiol., 2002, 40, 1006.
188. Pacher, P.; Liaudet, L.; Soriano, F.G.; Mabley, J.G.; Szabo, E.; Szabo, C. Diabetes, 2002, 51, 514.
189. Pacher, P.; Mabley, J.G.; Soriano, F.G.; Liaudet, L.; Komjati, K.; Szabo, C. Br. J. Pharmacol., 2002, 135, 1347.
190. Pacher, P.; Mabley, J.G.; Soriano, F.G.; Liaudet, L.; Szabo, C. Int. J. Mol. Med., 2002, 9, 659.
191. Guilford Pharmaceuticals Inc. US (Pub. No.) 2002/0037904, 2002.
192. Guilford Pharmaceuticals Inc. WO 02/06240, 2002.
193. Guilford Pharmaceuticals Inc. US (Pub. No.) 2002/0022636, 2002.
194. Tseng, A.; Lee, W.M.; Jakobovits, E.B.; Kirsten, E.; Hakam, A.; McLick, J.; Buki, K.; Kun, E. Proc. Natl. Acad. Sci. U.S.A., 1987, 84, 1107.
195. Buki, K.; Bauer, P.; Mendeleyev, J.; Hakam, A.; Kun, E. FEBS Left., 1991, 290, 181.
196. Szabó, C.; Wong, H.R.; Bauer, P.I.; Kirsten, E.; O'Connor, M.; Zingarelli, B.; Mendeleyev, J.; Hasko, G.; Vizi, E.S.; Salzman, A.L.; Kun, E. Int. J. Oncol., 1997, 10, 1093.
197. Endres, M.; Scott, G.S.; Salzman, A.L.; Kun, E.; Moskowitz, M.A.; Szabo, C. Eur. J. Pharmacol., 1998, 351, 377.
198. Cole, G.A.; Bauer, G.; Kirsten, E.; Mendeleyev, J.; Bauer, P.I.; Buki, K.G.; Hakam, A.; Kun, E. Biochem. Biophys. Res. Commun., 1991,180, 504.
199. Chuang, A.J.; Killam, K.F. Jr.; Chuang, R.Y.; Rice, W.G.; Schaeffer, C.A.; Mendeleyev, J.; Kun, E. FEBS Lett., 1993, 326, 140.
200. Guilford Pharmaceuticals Inc. US (Pub. No.) 2002/0028813.
201. N-Gene Kutato KFT. WO 00/14054, 2000.
202. N-Gene Kutato KFT. WO 01/70674, 2001.
203. Guilford Pharmaceuticals Inc US (Pub. No.) 2001/0020013, 2001.
204. Ruf, A.; de Murcia, G.; Schulz, G.E. Biochemistry, 1998, 37, 3893.
205. Ruf, A.; Rolli, V.; de Murcia, G.; Schulz, G.E. J. Mol. Biol., 1998, 278, 57.
206. Ruf, A,; Menissier-de Murcia, J.; de Murcia, G.; Schulz, G.E. Proc. Natl. Acad. Sci. U.S.A., 1996, 37, 7481.
207. Constantino, G.; Macchiarulo, A.; Camaioni, E.; Pellicciari, R. J. Med. Chem., 2001, 44, 3786.
208. De Murcia, J.M.; Niedergang, C.; Trucco, C.; Ricoul, M.; Dutriilaux, B.; Mark, M.; Oliver, F.J.; Masson, M.; Dierich, A.; LeMeur, M.; Walztinger, C.; Chambon, P.; De Murcia, G. Proc. Natl. Acad. Sci. USA, 1997, 94, 7303.
209. Trucco, C.; Oliver, F.J.; De Murcia, G.; Menissier-De Murcia, J. Nucleic Acids Res., 1998, 26, 2644.
210. Dantzer, F.; Nasheuer, H.P.; Vonesch, J.L.; De Murcia, G.; Menissier-De Murcia, J. Nucleic Acids Res., 1998, 26, 1891.
211. Masson, M.; Niedergang, C.; Schreiber, V.; Muller, S.; Menissier-De Murcia, J.; De Murcia, G. Mol. Cell Biol., 1998, 18, 3563.
212. Simbulan-Rosenthal, C.M.; Ly, D.H.; Rosenthal, D.S.; Konopka, G.; Luo, R.; Wang, Z.Q.; Schultz, P.G.; Smulson, M.E Proc. Natl. Acad. Sci. USA, 2000, 97, 11274.
213. Simbulan-Rosenthal, C.M.; Rosenthal, D.S.; Luo, R.; Li, J.H.; Zhang, J.; Smulson, M.E. Nucleic Acids Res., 2001, 29, 841.
214. Tsutsumi, M.; Masutani, M.; Nozaki, T.; Kusuoka, O.; Tsujiuchi, T.; Nakagama, H.; Suzuki, H.; Konishi, Y.; Sugimura, T. Carcinogenesis, 2001, 22, 1.
215. Conde, C.; Mark, M.; Oliver, F.J.; Huber, A.; De Murcia, G.; Menissier-De Murcia, J. Loss of Poly(ADP-Ribose) Polymerase-1 Causes Increased Tumour Latency in P53-Deficient Mice. EMBO J., 2001, 20, 3535.
216. Tong, W.M.; Hande, M.P.; Lansdorp, P.M.; Wang, Z.Q. Mol. Cell Biol., 2001, 21, 4046.
217. Canan, K.S.S.; Thoresen, L.H.; Tikhe, J.G.; Maegley, K.A.; Almassy, R.J.; Li, J.; Yu, X.H.; Zook, S.E.; Kumpf, R.A.; Zhang, C.; Boritzki, T.J.; Mansour, R.N.; Zhang, K.E.; Ekker, A.; Calabrese, C.R.; Curtin, N.J.; Kyle, S.; Thomas, H.D.; Wang, L.Z.; Calvert, A.H.; Golding, B.T.; Griffin, R.J.; Newell, D.R.; Webber, S.E.; Hostomsky, Z. J. Med. Chem., 2002, 45, 4961.
218. Cephalon Inc. WO 02/17914, 2002.